chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: HEP
Symptoms: Incomplete course of vaccination
Clinical narrative: patient received first dose of Engerix-B vaccine and has not received any additional doses.; This non-serious case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a 37-year-old female patient who received HBV (Engerix B) for prophylaxis.   Previously administered products included Engerix B (received first dose of Engerix B on 07-JAN-2024, batch number XS27B and expiry date 17 MAR 2025).   On an unknown date, the patient did not received the 2nd dose of Engerix B. On an unknown date, an unknown time after receiving Engerix B, the patient experienced incomplete course of vaccination (Verbatim: patient received first dose of Engerix-B vaccine and has not received any additional doses.). The outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 29-MAY-2024 The nurse stated patient received first dose of Engerix-B vaccine and has not received any additional doses.  The nurse indicated the patient was in a correctional facility.  Till the time of reporting, the patient did not receive 2nd dose of Engerix-B, which led to incomplete course of vaccination. The reporter did not consent to follow-up and declined to provide patient initials.
Sex: U
Vaccine: HEP
Symptoms: Product storage error
Clinical narrative: Product Storage Error and Possible Administration/not 100 percent sure that some of the vaccines have not been administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in an unspecified number of patients who received HBV (Engerix B Junior) (batch number EP724, expiry date 14-MAR-2025) and (batch number 42B22, expiry date 07-MAR-2026) for prophylaxis.   On an unknown date, the patient received Engerix B Junior. On an unknown date, an unknown time after receiving Engerix B Junior, the patient experienced incorrect storage of drug (Verbatim: Product Storage Error and Possible Administration/not 100 percent sure that some of the vaccines have not been administered). The outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 29-MAY-2024 On 10th October 2023 Lot: EP724 48.7 Fahrenheit for 35 minutes for 1 box and 34.3 Fahrenheit for 18 minutes. Prior on 5th May and 6th May Engerix-B maximum temperature of 55.0 Fahrenheit for a cumulative time of 6 hours, 34 minutes. The registered nurse stated that Engerix-B was exposed on 25th May 54.7 Fahrenheit for 11 hours, 11 minutes. On 26th May 55.2 Fahrenheit for 14 hours, 45 minutes. On 27th May 54.5 Fahrenheit for 3 hours, 58 minutes. The reporter stated that she was not 100 percent sure that some of the vaccines had not been administered which led to incorrect storage of drug.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Product preparation issue
Clinical narrative: she did not combined the vials/she just give the liquid portion with out mixing it; she did not combined the vials/she just give the liquid portion with out mixing it; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 56-year-old female patient who received Herpes zoster (Shingrix) (batch number 2SK93, expiry date 16-MAY-2026) and (batch number 3322C, expiry date 16-MAY-2026) for prophylaxis.   On 30-MAY-2024, the patient received Shingrix. On 30-MAY-2024, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: she did not combined the vials/she just give the liquid portion with out mixing it) and inappropriate dose of vaccine administered (Verbatim: she did not combined the vials/she just give the liquid portion with out mixing it). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date:30-MAY-2024 The reporter reported that one of the nurses in the office reported related to Shingrix vaccine.  Shingrix was 2 vials and she did not combined the vials and she just gave the liquid portion with out mixing them which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. She did not realize until the patient left. The vaccine administration facility was the same as primary reporter.
Age: 12.0
Sex: F
Vaccine: DTAP
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Wrong age/accidentally administered Infanrix to a 12 year old patient; accidentally administered Infanrix instead of administering the corresponding Tetanus, Diphtheria, Pertussis vaccine; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 12-year-old female patient who received DTPa (Infanrix) (batch number 9PT2F, expiry date 10-MAR-2026) for prophylaxis.   Previously administered products included Tdap (received 1st dose on 30-JAN-2012), Tdap (received 2nd dose on 09-APR-2012), Tdap (received 3rd dose on 13-JUN-2012), Tdap (received 4th dose on 02-JUL-2013) and Tdap (received 5th dose on 24-FEB-2016).   On 29-MAY-2024, the patient received Infanrix. On 29-MAY-2024, an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Wrong age/accidentally administered Infanrix to a 12 year old patient) and wrong vaccine administered (Verbatim: accidentally administered Infanrix instead of administering the corresponding Tetanus, Diphtheria, Pertussis vaccine). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 30-MAY-2024 The medical assistant stated that they accidently administered a sixth dose of Infanrix vaccine (Diphtheria, Tetanus, and Acellular Pertussis vaccine) instead of administering the corresponding Tetanus, Diphtheria, Pertussis vaccine, which led to wrong vaccine administered. The patient received a dose of Infanrix above than the recommended age limit, which led to inappropriate age at vaccine administration.
Age: 10.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Product administered to patient of inappropriate age, Product prescribing error
Clinical narrative: inadvertently administered Kinrix to a 10 year old; provider just ordered the wrong vaccine; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 10-year-old male patient who received DTPa-IPV (Kinrix) (batch number 3RT93, expiry date 03-APR-2026) for prophylaxis.   On 30-MAY-2024, the patient received Kinrix. On 30-MAY-2024, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: inadvertently administered Kinrix to a 10 year old) and wrong vaccine administered (Verbatim: provider just ordered the wrong vaccine). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 30-MAY-2024 Registered Nurse called to inquire if there was any potential side effects for this patient. Registered Nurse (RN) reported that they inadvertently administered Kinrix to a 10 year old patient, which led to inappropriate age at vaccine administration. The reporter mentioned the provider just ordered the wrong vaccine and it was mistakenly administered, which led to wring vaccine administered. The reporter did not consent to follow-up.
Age: 12.0
Sex: M
Vaccine: DTAP
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Infanrix - Dtap instead of Tdap; Infanrix - Dtap instead of Tdap; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 12-year-old male patient who received DTPa (Infanrix) (batch number 9PT2F, expiry date 10-MAR-2026) for prophylaxis.   On 30-MAY-2024, the patient received Infanrix. On 30-MAY-2024, an unknown time after receiving Infanrix, the patient experienced wrong vaccine administered (Verbatim: Infanrix - Dtap instead of Tdap) and inappropriate age at vaccine administration (Verbatim: Infanrix - Dtap instead of Tdap). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 30-MAY-2024 The Medical assistant asked for the information regarding the administration of Infanrix (Dtap) to 12 year old patient instead of Tdap vaccine which led to Wrong vaccine administered and Inappropriate age at vaccine administration. The reporter consented to follow up.
Age: 11.0
Sex: M
Vaccine: TDAP
Symptoms: Aggression, Circumstance or information capable of leading to medication error, Injection site discharge, Needle issue, Underdose
Clinical narrative: Not sure how much of the vaccine was administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete dose administered in a 11-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number F4T5L, expiry date 20-JUN-2026) for prophylaxis.   Concurrent medical conditions included autistic disorder.   On 31-MAY-2024, the patient received Boostrix. On 31-MAY-2024, an unknown time after receiving Boostrix, the patient experienced incomplete dose administered (Verbatim: Not sure how much of the vaccine was administered). The outcome of the incomplete dose administered was unknown.   Additional Information: GSK Receipt Date: 31-MAY-2024 The nurse reported while administering the Boostrix to an autistic patient he became quiet combative during the administration so the vaccine started coming out of the arm. The nurse typically changed needle and finished administering what was left, however during the situation and the combatantiness of the patient when it came out it caused the needle to bend and given the situation. They could not find the safety device so she just tossed it in the sharps container.  The vaccine was not spilled into eye and nurse was not sure how much of the vaccine was administered. They wanted some guidance on what they need to do, another vaccine or wait or re-administer. The patient did not received full dose of Boostrix, which led to needle issue and incomplete dose administered. The reporter consented to follow up.
Sex: F
Vaccine: HEPA
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Late second dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a adult female patient who received HAV (Havrix) for prophylaxis.   Previously administered products included Havrix (received 1st dose on 01-JUL-2019).   On 30-MAY-2024, the patient received the 2nd dose of Havrix. On 30-MAY-2024, an unknown time after receiving Havrix, the patient experienced drug dose administration interval too long (Verbatim: Late second dose). The outcome of the drug dose administration interval too long was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 31-MAY-2024 The pharmacist reported that a patient came yesterday (day before reporting) to receive Havrix, but then they noticed that patient received a first dose of Havrix vaccine on earlier date. The patient received the 2nd dose of Havrix delayed than the recommended time interval, which led to lengthening of the vaccination schedule.
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: experiencing persistent pain; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PAIN (experiencing persistent pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.   In 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced PAIN (experiencing persistent pain). At the time of the report, PAIN (experiencing persistent pain) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered PAIN (experiencing persistent pain) to be related.    Concomitant medication was not reported.  It was reported that, three years ago, patient received the Moderna COVID-19 vaccine and had since been experiencing persistent pain that suspect may be related to an adverse reaction from the vaccine. Despite seeking medical help, they have not been able to find adequate information or treatment to alleviate his symptoms. They believe that this pain could be attributed to a unique adverse side effect, possibly involving the production of a protein triggering an immune.  Treatment medication was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jun-2024: Live Follow up received contains non-significant information: Reference number added.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Movement disorder, Restless arm syndrome
Clinical narrative: Restless arm syndrome; Uncontrollable urge to move forearm and hands; This spontaneous case was reported by a patient and describes the occurrence of RESTLESS ARM SYNDROME (Restless arm syndrome) and MOVEMENT DISORDER (Uncontrollable urge to move forearm and hands) in a 64-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-May-2024, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) 1 dosage form. On 28-May-2024, the patient experienced RESTLESS ARM SYNDROME (Restless arm syndrome) and MOVEMENT DISORDER (Uncontrollable urge to move forearm and hands). At the time of the report, RESTLESS ARM SYNDROME (Restless arm syndrome) and MOVEMENT DISORDER (Uncontrollable urge to move forearm and hands) had not resolved.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) was unknown.       No concomitant medications were reported. Patient's symptoms initially happened night after vaccine. Continued to have this off and on. The symptoms were more severe at night. No treatment medications were provided.
Age: 30.0
Sex: F
Vaccine: HPV9, PNC20
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Pt came in rushing stating her daughter had a kindergarten graduation. I scanned medication but NDC did not take. Pt stated she had to go as the graduation was at 9:15 am and it was about 9:05 am. I proceeded to give vaccine to patient, and I realized the vaccine had not been properly scanned, pt then stated she had to go. I stayed behind trying to figure out the system issue, after I entered the NDC it appeared as prevnar 20. When I noticed the error, I informed Dr. and then contacted the patient. I informed her I had erroneously given her the prevnar 20 which can be given at her age, i reassured her. However, she would need to come back for dose ##3 of HPV. Pt was understanding and came back later on around 11:15 with normal vital signs and stable. Denied any adverse reactions. I gave her HPV dose #3 and pt left. today 6/10/24 I contacted pt and she states she is well and no problems or concerns.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: patient is having no problems
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: patient had no problems
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Death after
Age: 14.0
Sex: M
Vaccine: HEPA, IPV, MNQ, VARCEL
Symptoms: Dizziness, Feeling hot, Nausea, Vomiting
Clinical narrative: Patient got nauseated, hot, and light-headed.  We gave him cool rags and fanned him as well as gave him water.  After 5 minutes, patient vomited a small amount and felt better.  We had him wait an additional 15 minutes during which he stated he felt fine and was able to leave the clinic.
Age: 63.0
Sex: F
Vaccine: HEP, HEP, HEPA
Symptoms: Underdose
Clinical narrative: The patient was given two 10mcg doses of Hepatitis B vaccine instead of the 20mcg doses prescribed by her physician for the 5th and 6th doses. The patient was informed of the error and the need for an additional 20mcg dose to complete the intended series. However, she prefers to wait until her scheduled appointment on 06/20/2024 before coming back to the office.
Age: 13.0
Sex: F
Vaccine: HEP
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient was admin the adult dose>  According to package insert this is still a valid immunization for a 13 yr old and it is also in database as a valid immunization as well.  Patient did not have any adverse reaction.
Age: 0.75
Sex: F
Vaccine: MENB
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Meningitis B vaccine was given to the infant rather than the Hepatitis B vaccine; no signs/symptoms at the time the infant left clinic this morning;
Age: 69.0
Sex: M
Vaccine: RSV
Symptoms: Erythema, Feeling hot, Joint swelling, Laboratory test, Muscle spasms
Clinical narrative: feeling "hot" sensation in body, cramping in all extremities, right knee and thigh with swelling, redness and warmth.
Age: 69.0
Sex: M
Vaccine: RSV
Symptoms: Peripheral swelling, Skin warm
Clinical narrative: feeling "hot" sensation in body, cramping in all extremities, right knee and thigh with swelling, redness and warmth.
Age: 1.33
Sex: M
Vaccine: MMRV, VARCEL
Symptoms: Extra dose administered, No adverse event, Wrong product administered
Clinical narrative: The Medical Assistant administered the Proquad and Varivax vaccines at the same visit instead of the Varivax and MMR. No adverse events have been reported. Physician has alerted Parent of this occurrence and advised on adverse events that could occur.
Age: 11.0
Sex: M
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: Bexsero given to 11 years old.  Should have received MCV4
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain, Pain in extremity
Clinical narrative: Pt reports having pain and numbness shooting down his left arm to his left ring finger.    Pt was assessed and able to move left arm.  Appt was scheduled with Dr. at 140p. But wife found an earlier appt and rescheduled with Dr. at 120p.  Pt left at 1135 and reports that his left arm was getting better.
Age: 33.0
Sex: F
Vaccine: HEP
Symptoms: Erythema, Pruritus, Swelling
Clinical narrative: Patient states redness, swelling, itching started occurring 2 days after the injection. Self-treatment and so far watching and waiting.
Age: 25.0
Sex: F
Vaccine: MMR
Symptoms: Burning sensation, Erythema, Headache, Herpes zoster, Malaise
Clinical narrative: pt stated experienced burning, constant itching initially in the first 24 hours, then a rash with hives that were red and puffy appeared with the itching becoming more intense., body aches occurred and general malaise. Today no rash is noted, states mild HA and she took 800mg Mortin for that which helped to take the edge off the pain, also states she vomited today.  Staes she was diagnosed with Shingles approx. 2-3 weeks ago.
Age: 25.0
Sex: F
Vaccine: MMR
Symptoms: Pain, Pruritus, Rash, Skin swelling, Urticaria
Clinical narrative: pt stated experienced burning, constant itching initially in the first 24 hours, then a rash with hives that were red and puffy appeared with the itching becoming more intense., body aches occurred and general malaise. Today no rash is noted, states mild HA and she took 800mg Mortin for that which helped to take the edge off the pain, also states she vomited today.  Staes she was diagnosed with Shingles approx. 2-3 weeks ago.
Age: 25.0
Sex: F
Vaccine: MMR
Symptoms: Vomiting
Clinical narrative: pt stated experienced burning, constant itching initially in the first 24 hours, then a rash with hives that were red and puffy appeared with the itching becoming more intense., body aches occurred and general malaise. Today no rash is noted, states mild HA and she took 800mg Mortin for that which helped to take the edge off the pain, also states she vomited today.  Staes she was diagnosed with Shingles approx. 2-3 weeks ago.
Age: 69.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus
Clinical narrative: Localized reaction that appeared the next morning - pt states that no side effects occurred the day of the immunization - she didn't notice anything utnil the next day. Red, burning, itchy localized reaction with mild induration around the site of immunization. Reaction still present today, 1 week after vaccine administration, although she said it has improved significantly - currently approximately 6 inches wide x 4 inches high. Pt states no other symptoms, and as the rxn was localized, she did not report this to her PCP. (Although pt's husband is a retired physician.)
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Arthralgia, Feeling hot, Headache, Injection site pain
Clinical narrative: By 11:00pm on 06/04/2024 I started having the side effects symptoms: At the injection site it felt like I had been shot with a .22 caliber bullet, mild to moderate muscle pain and joint pain throughout my entire body, malaise, I felt warm, but my temperature was normal, intense headache at the posterior base of my skull and left side of my head just above the temple area, stomach, uneasiness, and stomach pain.     The side effects started out milder at 11:00pm that night, but had increased by the next morning. For treatment I rested and took some Tylenol.    The side effects, we?re starting to resolve by 11:00pm on 06/05/2024, and had completely resolved by 8:00am on 06/06/2024.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Malaise, Myalgia, Nausea
Clinical narrative: By 11:00pm on 06/04/2024 I started having the side effects symptoms: At the injection site it felt like I had been shot with a .22 caliber bullet, mild to moderate muscle pain and joint pain throughout my entire body, malaise, I felt warm, but my temperature was normal, intense headache at the posterior base of my skull and left side of my head just above the temple area, stomach, uneasiness, and stomach pain.     The side effects started out milder at 11:00pm that night, but had increased by the next morning. For treatment I rested and took some Tylenol.    The side effects, we?re starting to resolve by 11:00pm on 06/05/2024, and had completely resolved by 8:00am on 06/06/2024.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Hypotonia, Loss of consciousness
Clinical narrative: Immunization was given at approximately 10:45 and about a minute later at 10:46 patient went limp and passed out on table. No signs or symptoms occurred before adverse event. Patient woke up within seconds of fainting and laid down for 5-10 minutes. Vitals were taken 3 times before patient left. Patient left approximately 30 minutes after adverse event.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Body temperature decreased, Chills, Dizziness, Fatigue, Feeling cold
Clinical narrative: started within 10ish hours of injection; ramped up significantly for approximately 4-6 hours; after about 12ish hours, started tapering off slowly; was basically symptom-free after roughly 36 hours; borderline hypothermic (95.8 deg F) for several hours: full body shaking, teeth chattering so hard it hurt & even sitting in front of a small space heater didn't reduce symptoms; aching joints like with flu; extreme fatigue to the point that even sitting up was exhausting; significant headache; intermittent dizziness; multiple periodic headrushes like the kind you get just before you pass out, but never actually passed out
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Influenza like illness, Pain, Tremor
Clinical narrative: started within 10ish hours of injection; ramped up significantly for approximately 4-6 hours; after about 12ish hours, started tapering off slowly; was basically symptom-free after roughly 36 hours; borderline hypothermic (95.8 deg F) for several hours: full body shaking, teeth chattering so hard it hurt & even sitting in front of a small space heater didn't reduce symptoms; aching joints like with flu; extreme fatigue to the point that even sitting up was exhausting; significant headache; intermittent dizziness; multiple periodic headrushes like the kind you get just before you pass out, but never actually passed out
Age: 20.0
Sex: M
Vaccine: MMR
Symptoms: Expired product administered
Clinical narrative: Patient received expired vaccine. Administered on 5/30/24. Product expired 5/10/2024.
Age: 72.0
Sex: F
Vaccine: PNC20, TDAP
Symptoms: Injection site erythema, Injection site swelling, Pain in extremity
Clinical narrative: Patient has complain about pain in left arm.  She has redness (a big patch) and the site is swollen. The patient went to the doctor office and per patient they doctor told her to follow up with pharmacy.  She went to the doctor for follow-up
Age: 16.0
Sex: F
Vaccine: MENB
Symptoms: Arthralgia, Muscular weakness, Rotator cuff syndrome, Tendon injury
Clinical narrative: Sore left arm, ibuprofen prescribed on 04/23/24. Shoulder impingment (weakness and pain in left  shoulder, started within 48 hours of administration), seen by ortho, recommended PT.
Age: 16.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Dizziness, Feeling hot, Hypopnoea
Clinical narrative: Approximately 3 minutes following the administration of the Gardasil 9 vaccine, IM to Left Deltoid, patient stated that she "feel like I'm going to pass out".  Patient was encouraged to lay down on exam table with her mother at her side and her legs were elevated.  Patient stated that she "felt hot" and her respirations were shallow with a rate of 24 per minute.  Patient never lost consciousness and rested for approximately 5 minutes before sitting up and saying that she "felt fine now".  Mother instructed to watch her daughter for the next 24 hours and follow up with her family doctor or ER should her daughter develop any difficulty breathing, dizziness, skin reactions, or nausea/vomiting.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Discomfort, Head discomfort, Musculoskeletal discomfort, Rash, Rash erythematous
Clinical narrative: Starting approximately 3 hours pos-vaccine: rash on left arm and discomfort in head, shoulders and body. Rash on left arm has increased in size and itching, also red, warm and painful.  Patient has tried Benadryl and Tylenol to help. Benadryl helps but induces fatigue.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash pruritic, Skin warm
Clinical narrative: Starting approximately 3 hours pos-vaccine: rash on left arm and discomfort in head, shoulders and body. Rash on left arm has increased in size and itching, also red, warm and painful.  Patient has tried Benadryl and Tylenol to help. Benadryl helps but induces fatigue.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, HIBV, PNC13, VARCEL
Symptoms: Product storage error
Clinical narrative: On January 9, 2024 the vaccines in the clinic were moved to Health Department due to a power outage. The power came back on around 9:30a.m. when I arrived to work but I was advised by my supervisor to move the vaccine still in case it took a while for the refrigerator to return to the proper temperature. Vaccines were packed with ice packs and bubble wrap and transported by CRNP. The vaccine was transported back to Health Department that afternoon. A temperature excursion was noted on the digital data logger. Once returned to clinic the data logger was found to be beside the ice packs instead of by the vaccine. The vaccine manufacturers of the affected vaccine were notified and made aware of the temperature excursion. I notified the companies that the vaccine reached a temperature of 1.8 degrees Celsius. The max temperature that the vaccine reached during transport was 12.0 degrees Celsius. Per the vaccine companies, the only vaccine that was not recommended to use was the opened vial of IPOL and the opened MDV of Fluzone. They were discarded per the vaccine companies? recommendations.  Moving forward to April 10, 2024. The vaccine was transported again to Health Department due to inclement weather that day. Vaccine was transported by my supervisor and returned on April 12, 2024. Another temperature excursion occurred when the vaccine was transported back to the clinic. The vaccine companies were again contacted for recommendations on viability of the vaccine. When contacting the vaccine companies, I was asked if any of the vaccines had undergone a previous temperature excursion. It was then when I pulled my documentation from the previous excursion that I realized I had read the temperature log incorrectly and that the vaccine had reached a temperature of negative 1.8 degrees Celsius instead of what I reported to the vaccine companies of a +1.8 Degrees Celsius. Therefore, in fact there were two 2 temp excursions one on January 9, 2024 and the other on April 12th, 2024.  A list of all patients that received vaccines between January 9-April 12th was compiled. The list was sorted through as to what patients received the affected vaccine. Patients were notified of questionable viability of vaccines and were offered and recommended to be revaccinated if desired. Notes were added into system for outside providers.  The process of packing vaccine during transport during emergencies had been reviewed by all staff to include packaging with conditioned water bottles instead of frozen ice packs. 04/30/24-Letter mailed to patient. 06/04/2024-Mom counseled that Kinrix and PCV13 underwent a temperature excursion;therefore,we cannot be certain of viability of vaccine. Child was re-vaccinated on 06/04/24 with DTAP and IPV. PCV13 not repeated due to patient now age 5 and not recommended.
Age: 62.0
Sex: F
Vaccine: HEPAB, RSV
Symptoms: Arthralgia, Mobility decreased, Pain, Pain in extremity
Clinical narrative: Patient states she has been having pain in the arm since she got the vaccine.  Pain shooting up the upper arm into the shoulder.  States at one point it locked up on her and she couldn't use that arm.  The doctor gave her a cortisone shot and it got better but now starting to have pain again.  She is seeing her doctor again soon for follow up.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Dizziness, Headache, Nausea
Clinical narrative: headache,diziness, naseau
Age: 17.0
Sex: M
Vaccine: MENB, MNQ
Symptoms: Dizziness, Face injury, Suture insertion, Syncope
Clinical narrative: Patient was given a Bexsero and Menveo injection in the office. About 20 minutes post vaccination the patient was standing at the front counter scheduling another appointment and he started to feel dizzy and had a syncopal episode. The patient struck his chin on the floor  resulting in sutures to the area.
Age: 28.0
Sex: F
Vaccine: MMR
Symptoms: Chills, Dysphagia, Feeling hot, Hyperhidrosis, Pyrexia
Clinical narrative: Pt called to report that 06/08/24 she started to feel cold chills;also feeling hot and sweaty at times.She had a fever of 101 yesterday.Yesterday morning she felt it was "hard to swallow".She has been able to swallow and stated that after she takes a few swallows,the symptom lessens.The symptom has been intermittent.I called her provider to tell them I advised her to come in to see her provider and I verified pt made appt.after I talked with her.
Age: 43.0
Sex: F
Vaccine: HPV9
Symptoms: Immediate post-injection reaction, Injection site erythema, Injection site swelling
Clinical narrative: Immediate swelling at the injection site, the size of an egg. Ice pack applied to the area and the swelling started subsiding after 5 minutes. Redness noted but no pain or itching per patient. No throat itching and no trouble breathing. Patient states she had a lot of pain (for 8 days) after her first dose of this vaccine. She denies having swelling like this after her first dose.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, Injection site swelling, Pain in extremity
Clinical narrative: Pt was given vaccine that had previously expired per the Beyond Use Date.  Dose BUD was 5/10/2024, dose was administered 5/13/24, Discovered 6/5/24.  Pt experienced normal side effects compared to previous doses (sore arm w/ slight swelling).
Age: 13.0
Sex: M
Vaccine: MNQ
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient was given a vaccination too early. First vaccine given at age 11 and not due until 16. No signs or symptoms that were abnormal.
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, Malaise, Pyrexia
Clinical narrative: Pt was given vaccine that had previously expired per the Beyond Use Date.  Dose BUD was 5/10/24, dose was administered 5/15/24, discovered 6/5/24.  Pt experienced fever and malaise for approximately one day but nothing out of the ordinary.
Age: 4.0
Sex: M
Vaccine: UNK
Symptoms: Injection site erythema, Injection site pain, Pyrexia
Clinical narrative: Patient received Pneumovax on Friday 6/7/2024. Started with a fever Friday night. Saturday Mom noticed there was redness at the site and painful to touch. PCP referred to ER for further eval after spiking a fever to 102.5 Sunday AM.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Pt was given vaccine that had previously expired per the Beyond Use Date.  Dose BUD was 5/10/24, dose was administered 5/19/24, discovered 6/5/24.  Pt did not experience any side effects from vaccine.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Pt was given vaccine that had previously expired per the Beyond Use Date.  Dose BUD was 5/10/24, dose was administered 5/19/24, discovered 6/5/24.  Pt did not experience any side effects from vaccine.
Age: 17.0
Sex: F
Vaccine: COVID19, MNQ
Symptoms: Expired product administered, No adverse event
Clinical narrative: This RN prepared and administered a Moderna Spikevax 12+ vaccine that was determined to be expired upon documentation. This RN alerted a nurse supervisor who then pulled the vaccine from the vaccine fridge and a clinic incident report was submitted. The patient experienced no adverse reaction or side effects. Patient will be notified.
Age: 77.0
Sex: F
Vaccine: RSV
Symptoms: Asthma, Condition aggravated, SARS-CoV-2 test negative, Upper respiratory tract infection
Clinical narrative: Patient reported upper respiratory infection and worsening of asthma symptoms
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Pt was given vaccine that had previously expired per the Beyond Use Date.  Dose BUD was 5/10/24, dose was administered 5/24/24, discovered 6/5/24.  Pt did not experience any side effects from vaccine.
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Product storage error
Clinical narrative: On January 9, 2024 the vaccines in the clinic were moved to Health Department due to a power outage. The power came back on around 9:30a.m. when I arrived to work but I was advised by my supervisor to move the vaccine still in case it took a while for the refrigerator to return to the proper temperature. Vaccines were packed with ice packs and bubble wrap and transported by CRNP. The vaccine was transported back to Health Department that afternoon. A temperature excursion was noted on the digital data logger. Once returned to clinic the data logger was found to be beside the ice packs instead of by the vaccine. The vaccine manufacturers of the affected vaccine were notified and made aware of the temperature excursion. I notified the companies that the vaccine reached a temperature of 1.8 degrees Celsius. The max temperature that the vaccine reached during transport was 12.0 degrees Celsius. Per the vaccine companies, the only vaccine that was not recommended to use was the opened vial of IPOL and the opened MDV of Fluzone. They were discarded per the vaccine companies? recommendations.  Moving forward to April 10, 2024. The vaccine was transported again to Health Department due to inclement weather that day. Vaccine was transported by my supervisor and returned on April 12, 2024. Another temperature excursion occurred when the vaccine was transported back to the clinic. The vaccine companies were again contacted for recommendations on viability of the vaccine. When contacting the vaccine companies, I was asked if any of the vaccines had undergone a previous temperature excursion. It was then when I pulled my documentation from the previous excursion that I realized I had read the temperature log incorrectly and that the vaccine had reached a temperature of negative 1.8 degrees Celsius instead of what I reported to the vaccine companies of a +1.8 Degrees Celsius. Therefore, in fact there were two 2 temp excursions one on January 9, 2024 and the other on April 12th, 2024.  A list of all patients that received vaccines between January 9-April 12th was compiled. The list was sorted through as to what patients received the affected vaccine. Patients were notified of questionable viability of vaccines and were offered and recommended to be revaccinated if desired. Notes were added into system for outside providers.  The process of packing vaccine during transport during emergencies had been reviewed by all staff to include packaging with conditioned water bottles instead of frozen ice packs. 05/09/2024-Phonecall to patients guardian. Discussed need to have HPV vaccine given on 02/08/2024 repeated due to temperature excursion. Explained that  we cannot be sure of effectiveness of vaccine so it is recommended that it be repeated .Appointment scheduled for June 4, 2024. Patient no showed for her appointment
Age: 76.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site rash, Rash
Clinical narrative: Full body circular non-raised rash which started at injection site and spread over whole body within 1 week after 1st dose.
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, Fatigue
Clinical narrative: Pt was given vaccine that had previously expired per the Beyond Use Date.  Dose BUD was 5/10/24, dose was administered 5/29/24, discovered 6/5/24.  Pt experienced fatigue for a few days post vaccination.
Age: 35.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Feeling hot, Palpitations
Clinical narrative: warm feeling in the chest and racing heart for about an hour after first injection
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Wrong product administered
Clinical narrative: Patient was suppose to be up for the Meningitis B shot. At previous appt nurse had charted meningitis #1 shot and gave MenQuadfi. and scheduled next visit for meningitis #2 so when looking at chart thought meningitis A was to be given. After going back into doctor note patient should have received meningitis B. Called patient on monday after confirming with the PCP that if she wants it or if her school requires it she can come abck in for a nurse visit for meningitis b shot.
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, Fatigue
Clinical narrative: Pt was given vaccine that had previously expired per the Beyond Use Date.  Dose BUD was 5/10/24, dose was administered 5/24/24, discovered 6/5/24.  Pt experienced some fatigue for a few days post vaccination
Age: 47.0
Sex: M
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: redness and warmth to vaccine injection site and bicep 1 day after vaccine
Age: 13.0
Sex: M
Vaccine: HPV9, MNQ
Symptoms: Product storage error
Clinical narrative: On January 9, 2024 the vaccines in the clinic were moved to County Health Department due to a power outage. The power came back on around 9:30a.m. when I arrived to work but I was advised by my supervisor to move the vaccine still in case it took a while for the refrigerator to return to the proper temperature. Vaccines were packed with ice packs and bubble wrap and transported by, CRNP. The vaccine was transported back to County Health Department that afternoon. A temperature excursion was noted on the digital data logger. Once returned to clinic the data logger was found to be beside the ice packs instead of by the vaccine. The vaccine manufacturers of the affected vaccine were notified and made aware of the temperature excursion. I notified the companies that the vaccine reached a temperature of 1.8 degrees Celsius. The max temperature that the vaccine reached during transport was 12.0 degrees Celsius. Per the vaccine companies, the only vaccine that was not recommended to use was the opened vial of IPOL and the opened MDV of Fluzone. They were discarded per the vaccine companies? recommendations.  Moving forward to April 10, 2024. The vaccine was transported again to County Health Department due to inclement weather that day. Vaccine was transported by my supervisor and returned on April 12, 2024. Another temperature excursion occurred when the vaccine was transported back to the clinic. The vaccine companies were again contacted for recommendations on viability of the vaccine. When contacting the vaccine companies, I was asked if any of the vaccines had undergone a previous temperature excursion. It was then when I pulled my documentation from the previous excursion that I realized I had read the temperature log incorrectly and that the vaccine had reached a temperature of negative 1.8 degrees Celsius instead of what I reported to the vaccine companies of a +1.8 Degrees Celsius. Therefore, in fact there were two 2 temp excursions one on January 9, 2024 and the other on April 12th, 2024.  A list of all patients that received vaccines between January 9-April 12th was compiled. The list was sorted through as to what patients received the affected vaccine. Patients were notified of questionable viability of vaccines and were offered and recommended to be revaccinated if desired. Notes were added into immprint for outside providers.  The process of packing vaccine during transport during emergencies had been reviewed by all staff to include packaging with conditioned water bottles instead of frozen ice packs. 04/30/24-Spoke with patient's mom on phone. Notified of need to repeat HPV and Meningitis vaccines given on 02/14/2024 due to vaccines undergoing a temperature excursion we cannot be certain of the effectiveness/viability of the vaccines. Appointment was scheduled for June 4th for child to be revaccinated.  Patient no showed June 4  for appointment. Chart remains flagged.
Age: 1.0
Sex: M
Vaccine: HEPA
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: My child was given an intramuscular vaccine on his left inner thigh.  No symptoms noted to site or in general.
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, Pain in extremity
Clinical narrative: Pt was given vaccine that had previously expired per the Beyond Use Date.  Dose BUD was 5/10/24, dose was administered 5/31/24, discovered 6/5/24.  Pt had soreness in his arm for approximately 4-5 days post vaccination.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Allergy to vaccine, Crying, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Noted localized redness, swelling, warmth at area of injection site 10 minutes after administration of MMR subcutaneously. Cold pack applied, patient assessed by nurse practitioner. Vitals obtained, patient active and crying,  no difficulty breathing, shortness of breath, or fever. Pulse rate 133 temp 97.9 axillary , respiration 28, current weight 21 lb and HC 18.9 cm. Spot check oxygen saturation 99% on room air.   Received 6.25 mg diphenhydramine oral and ibuprofen 90 mg oral. Patient reassessed following medication administration, redness and swelling reduced. Patient discharged home under care of mother. Allergy to MMR vaccine placed in chart.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Blood bilirubin increased, Headache, Influenza like illness, Lethargy
Clinical narrative: After the first dose, I experienced pain and swelling in my  axillary lymph nodes. I sought advice of a pharmacist.  After the second dose,  the swelling continued and I had other minor flu like symptoms. Within 3 weeks, I became very sick, symptoms include abdominal pain, vomiting, 103 fever, lethargy, headache, body aches, tachycardia,
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Malaise, Neutrophil percentage increased, Pain, Pyrexia
Clinical narrative: After the first dose, I experienced pain and swelling in my  axillary lymph nodes. I sought advice of a pharmacist.  After the second dose,  the swelling continued and I had other minor flu like symptoms. Within 3 weeks, I became very sick, symptoms include abdominal pain, vomiting, 103 fever, lethargy, headache, body aches, tachycardia,
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia, Vomiting, White blood cell count increased
Clinical narrative: After the first dose, I experienced pain and swelling in my  axillary lymph nodes. I sought advice of a pharmacist.  After the second dose,  the swelling continued and I had other minor flu like symptoms. Within 3 weeks, I became very sick, symptoms include abdominal pain, vomiting, 103 fever, lethargy, headache, body aches, tachycardia,
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site discolouration, Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: The patient received a shingrix shot dose 1 on 06/04/2024 and returned to the clinic on 06/10/2024 stating that her left upper arm was itchy and red and has been since 06/07/2024.  The patient with 4 inch diameter raised circular hyperpigmented patch, triamcinolone 0.1  mg ever 12 hours for 7 days and medrol dose pack 4 mg, take as directed, 21 tablets, prescribed.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Facial pain, Pruritus
Clinical narrative: Client presents to clinic with left-side face pain; "mostly by the mouth."  Says it started yesterday and it feels like she wants to "itch her face off" and it "burns."  Client questioning if it is related to the Shingrix vaccine.
Age: 9.0
Sex: F
Vaccine: TYP
Symptoms: Contusion, Dizziness, Fall, Odynophagia, Rash
Clinical narrative: HIVES SMALL RASHES ON FACE, PAINFUL THROAT WHEN SWALOWING FOOD, FELT DIZZY AND FELL IN SCHOOL AND BRISED HER KNEES BADLY, BIG ABRASION ON RIGHT AND LEFT KNEE
Age: 9.0
Sex: F
Vaccine: TYP
Symptoms: Skin abrasion, Urticaria
Clinical narrative: HIVES SMALL RASHES ON FACE, PAINFUL THROAT WHEN SWALOWING FOOD, FELT DIZZY AND FELL IN SCHOOL AND BRISED HER KNEES BADLY, BIG ABRASION ON RIGHT AND LEFT KNEE
Age: 25.0
Sex: F
Vaccine: TD, VARCEL
Symptoms: Blister, Injection site erythema, Injection site induration, Injection site pain, Injection site swelling
Clinical narrative: 10+ small fluid filled blisters developed on chest and arm one day after vaccination. Hard, painful, red bump about 4 inches in diameter developed at the site of injection starting day after vaccination.
Age: 82.0
Sex: M
Vaccine: VARZOS
Symptoms: Pain, Pain in extremity
Clinical narrative: Severe arm pain upon lifting
Age: 1.0
Sex: F
Vaccine: HIBV
Symptoms: No adverse event, Product preparation error
Clinical narrative: HIB was given with Sterile diluent instead of the diluent it comes with. Patient had no reaction to vaccine.